Does rifaximin decrease the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis?
Long-term use of rifaximin is associated with a decrease incidence of AKI and HRS and a decrease risk of requiring RRT in a general population of cirrhotic patients.
Results suggest that enhancing a more positive attitude toward having epilepsy might help improve problems with poor self-concept or behavior problems, but might not influence social competence.